Shiseido Returns to Profit in Q3 2026 Despite Drunk Elephant Sales Slump
Shiseido reached profitability in the third quarter of 2026 as net sales for the year’s first nine months rose to ¥741.1bn. According to Cosmetics Business, the Japanese conglomerate benefited from strong momentum in its core brands and travel retail, even as subsidiary Drunk Elephant struggled with a double-digit decline in global sales.
Context from Industry Pulse
Shiseido’s current financial standing reflects a stark contrast between its legacy prestige brands and its newer acquisitions. While the core Shiseido and Cle de Peau Beaute lines provide stability and growth, Drunk Elephant is struggling to regain its footing after a highly publicized identity crisis. The brand attempted a strategic reset in early 2026 to distance itself from the Sephora Kids social media phenomenon, which saw younger consumers flocking to high-potency products. Despite these rebranding efforts, the sustained sales decline suggests that the label has yet to stabilize its market position, directly impacting Shiseido’s e-commerce performance in the United States.
The latest financial data highlights a significant turnaround for the beauty giant following a challenging fiscal start. According to reporting by Cosmetics Business, core operating profit surged 124 percent to ¥67.5bn, a substantial jump from the ¥30.1bn recorded during the same period in the previous year. This performance shifted the core operating margin to 9.1 percent of net sales, up from just 4.3 percent. Shiseido also moved back into the black with a profit before tax of ¥65.3bn, successfully reversing a loss of ¥32.5bn from the prior year.
The recovery was largely fueled by the strength of the company’s namesake label and the luxury brand Cle de Peau Beaute. As Cosmetics Business notes, new ventures also contributed to the positive trajectory, including the recent launch of Max Mara fragrances and specific product innovations like the Elixir line’s Total V Cream. While sales momentum had dipped slightly in the first quarter, the company saw steady improvements throughout the year, culminating in a 3 percent growth rate for the third quarter.
However, Drunk Elephant remains a significant point of concern for the parent company. As Cosmetics Business reports, the skincare brand saw its global sales plummet 23 percent during the quarter, accelerating from a 14 percent drop in the second quarter. This decline has been attributed to ongoing branding challenges and the fallout from previous controversies regarding the brand’s target demographic and product usage by younger consumers. The underperformance of Drunk Elephant and Dr. Dennis Gross Skincare acted as a primary detractor from the group’s overall results.
In the travel retail sector, Shiseido observed a modest recovery with net sales climbing to ¥268.5bn. Cosmetics Business indicates that while the pace of recovery in Mainland China and general travel retail remains slower than initially forecast, specific regions like Hainan Island are showing growth. The company maintains an optimistic outlook regarding the easing of retailer restructuring in China, though it remains cautious and intends to manage shipments based on real-time consumer purchase trends.
The Industry Pulse Bottom Line
Shiseido’s return to profitability proves the resilience of its heritage prestige portfolio, but the severe underperformance of Drunk Elephant indicates that reclaiming brand equity after a demographic controversy is a long-term challenge for the group.